Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy [NA]

View source ↗

Summary

This clinical trial update indicates a study evaluating the hypoallergenic potential of a hydrolyzed rice protein-based infant formula for infants and young chi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrolyzed rice protein-based infant formula (Hydrolyzed rice protein-based infant formula)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Cow's Milk Protein Allergy | NA | Status: RECRUITING